Cell Death Discovery (Jun 2022)

Transcription factor Sp9 is a negative regulator of D1-type MSN development

  • Zhenmeiyu Li,
  • Zicong Shang,
  • Mengge Sun,
  • Xin Jiang,
  • Yu Tian,
  • Lin Yang,
  • Ziwu Wang,
  • Zihao Su,
  • Guoping Liu,
  • Xiaosu li,
  • Yan You,
  • Zhengang Yang,
  • Zhejun Xu,
  • Zhuangzhi Zhang

DOI
https://doi.org/10.1038/s41420-022-01088-0
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 12

Abstract

Read online

Abstract The striatum is the main input structure of the basal ganglia, receiving information from the cortex and the thalamus and consisting of D1- and D2- medium spiny neurons (MSNs). D1-MSNs and D2-MSNs are essential for motor control and cognitive behaviors and have implications in Parkinson’s Disease. In the present study, we demonstrated that Sp9-positive progenitors produced both D1-MSNs and D2-MSNs and that Sp9 expression was rapidly downregulated in postmitotic D1-MSNs. Furthermore, we found that sustained Sp9 expression in lateral ganglionic eminence (LGE) progenitor cells and their descendants led to promoting D2-MSN identity and repressing D1-MSN identity during striatal development. As a result, sustained Sp9 expression resulted in an imbalance between D1-MSNs and D2-MSNs in the mouse striatum. In addition, the fate-changed D2-like MSNs survived normally in adulthood. Taken together, our findings supported that Sp9 was sufficient to promote D2-MSN identity and repress D1-MSN identity, and Sp9 was a negative regulator of D1-MSN fate.